#trademark
Related Stories (6)
Backlash after China bubble tea firm ordered to pay Louis Vuitton $1.5m
A court in China ruled that Molly Tea had infringed on the luxury brand's four-petal flower design.
July 6, 2026Swatch claiming $170 million in damages against Samsung over trademark infringement, FT reports - Reuters
Swatch claiming $170 million in damages against Samsung over trademark infringement, FT reports Reuters
June 26, 2026Toronto cannabis shop rides high over FIFA legal notice - Reuters
Toronto cannabis shop rides high over FIFA legal notice Reuters
June 15, 2026Luke Littler applies to trademark his face to combat AI fakes
The darts star's image has been used legally on darts merchandise, snacks and fashion brands.
March 20, 2026Australian designer Katie Perry wins trademark appeal vs Katy Perry
The US singer lost the case in 2023 and later won on appeal, but now judges have ruled against her.
March 11, 2026Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say - Reuters
Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say Reuters
February 25, 2026Related Pages (4)
Backlash after China bubble tea firm ordered to pay Louis Vuitton $1.5m
Molly Tea's four-petal flower logo Popular Chinese tea chain Molly Tea has been ordered to pay 10.3m yuan (£1.1m; $1.5m) in damages after a court ruled that its logo infringed a Louis Vuitton tradema
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
FIFA demands pot shop stop selling bong resembling World Cup trophy
A Toronto cannabis shop selling bongs that resemble the World Cup trophy has been given a red card from the tournament’s organizer. Cosmic Charlies co-owner Sean Kady said a law firm representing FIF
Dr Reddy's files 'Obeda' trademark ahead of generic ozempic launch
Hyderabad-based Dr Reddy’s Laboratories has applied to trademark the brand name and logo “Obeda”, according to sources. The proposed brand is expected to be the company’s version of semaglutide, the